Ception Therapeutics Overview
- Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$250M
Ception Therapeutics General Information
Description
Developer of biopharmaceuticals engaged in the discovery, development, and commercialization of new drugs and therapies for difficult to treat illnesses. The company offers Reslizumab for eosinophilic inflammatory conditions. It also provides Anti-TNF, a class of small molecule anti-TNF receptor agents with the potential to be orally administered. The companies portfolio includes treatments for central nervous system disorders, pain and cancer and include eight proprietary products in the United States, along with more than 100 products internationally. Cephalon's research pipeline is focused on developing new compounds and new indications for existing products, while their business collaborations capitalize on new products and smart drug delivery technologies.
Contact Information
- 101 Lindenwood Drive
- Suite 400
- Malvern, PA 19355
- United States
Ception Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 05-Apr-2010 | $250M | 00000 | 00000 | Completed | Clinical Trials - Phase 2 |
| 5. Later Stage VC | 14-Oct-2008 | 0000 | 00000 | Completed | Startup | |
| 4. Later Stage VC (Series C) | 31-May-2007 | 0000 | 0000 | Completed | Startup | |
| 3. Early Stage VC (Series B) | Completed | Startup | ||||
| 2. Early Stage VC (Series A) | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Ception Therapeutics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Aperture Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Astellas Venture Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| EW Healthcare Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Greenlight Capital | Hedge Fund | Minority | 000 0000 | 000000 0 | |
| Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |
Ception Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 (0000 | 01-Dec-2005 | 0000000000 | Discovery Tools (Healthcare) |